Clinical Trials Sponsored by Alimera Sciences
Total 19432 results
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis BUnited States
-
Gilead SciencesCompletedHIV | Human Immunodeficiency Virus | HIV-1United States, Puerto Rico
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Kathmandu University School of Medical SciencesNorwegian University of Science and TechnologyRecruitingUrinary IncontinenceNepal
-
School of Health Sciences GenevaGerman Research Foundation; Swiss National Science FoundationCompletedAge-related Cognitive DeclineSwitzerland
-
Norwegian University of Science and TechnologyKathmandu University School of Medical SciencesCompleted
-
Norwegian University of Science and TechnologyWestern Norway University of Applied SciencesCompletedObesity | Musculoskeletal Disease | Psychological DisorderNorway
-
China Academy of Chinese Medical SciencesNational Natural Science Foundation of ChinaCompletedIschemic Stroke | ConvalescenceChina
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States, Israel
-
Gilead SciencesRecruitingStudy of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus (MARASLE)Rheumatoid Arthritis | Systemic Lupus ErythematosusUnited States, United Kingdom, Georgia, Moldova, Republic of
-
Gilead SciencesRecruitingUlcerative ColitisUnited States, Australia, United Kingdom, Korea, Republic of, Japan, Italy, France, Canada, Switzerland, Austria, Germany, Hungary, Poland
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Gilead SciencesRecruitingChronic Hepatitis D InfectionUnited States
-
Gilead SciencesRecruitingCutaneous Lupus Erythematosus (CLE)United States, Spain, Czechia, Germany
-
Gilead SciencesRecruitingHIV-1-infectionJapan, Germany, France, United States, Spain, Korea, Republic of, South Africa, Australia, Argentina, Canada, Dominican Republic, Italy, Puerto Rico, Taiwan, United Kingdom
-
Gilead SciencesRecruiting
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
Gilead SciencesRecruitingLiver Failure | Advanced or Metastatic Solid TumorFrance, United States
-
Gilead SciencesRecruitingChronic Hepatitis BUnited States, Taiwan, Korea, Republic of, India, New Zealand, Belgium, Canada, Italy, Romania, Russian Federation, Hong Kong
-
Gilead SciencesRecruitingHIV Infections | Acquired Immune Deficiency Syndrome (AIDS)United States, South Africa, Argentina, Panama, Thailand, Zimbabwe, United Kingdom, Uganda
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Spain, Belgium, United Kingdom, Germany, Australia, Hong Kong, Denmark, France, Japan, Canada, Italy, Austria, Sweden, Switzerland
-
Gilead SciencesTerminatedCutaneous Lupus ErythematosusUnited States
-
Gilead SciencesActive, not recruitingChronic Hepatitis BTaiwan, New Zealand
-
Gilead SciencesTerminated
-
Gilead SciencesActive, not recruitingSolid TumorSpain, United Kingdom, United States, France, Poland
-
Gilead SciencesActive, not recruitingNon-Small Cell Lung CancerUnited States, Belgium, Spain, United Kingdom, Australia, Japan, Italy, France, Israel, Netherlands, Puerto Rico, Portugal, Greece, Brazil, Poland, Canada, Austria, Germany, Mexico, Turkey
-
Gilead SciencesCompletedCOVID-19United States, Japan
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Italy
-
Gilead SciencesTerminatedMetastatic Colorectal Cancer | Rectal Cancer | Colon CancerUnited States
-
Gilead SciencesActive, not recruitingHIV InfectionsUnited States, Australia, Puerto Rico, Canada
-
Gilead SciencesActive, not recruitingPre-Exposure Prophylaxis of HIV InfectionUnited States, Thailand, Brazil, Peru, Argentina, South Africa, Mexico, Puerto Rico
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
Gilead SciencesActive, not recruitingChronic Hepatitis BUnited States, Taiwan, Korea, Republic of, Romania, India
-
Gilead SciencesTerminatedCOVID-19Spain, Japan, Korea, Republic of, Taiwan, Bulgaria, Mexico, South Africa, United Kingdom, Portugal, Romania, Hungary, Brazil, Canada, France, Italy, Poland, Singapore, Turkey
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Gilead SciencesTerminatedHuman Immunodeficiency Virus Type 1 (HIV-1) InfectionUnited States
-
Gilead SciencesCompletedHIV-1-infectionUnited States, Puerto Rico, Dominican Republic
-
Gilead SciencesCompletedHBeAg-positive Chronic Hepatitis BHong Kong, Korea, Republic of, United States, Taiwan, United Kingdom, France, Australia, Spain, Bulgaria, Canada, India, Italy, Japan, New Zealand, Poland, Romania, Russian Federation, Singapore, Turkey
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
Gilead SciencesTerminatedCOVID-19Spain, United States, United Kingdom, Portugal, Brazil, South Africa
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
Gilead SciencesCompletedDiabetic Kidney DiseaseUnited States, Japan, New Zealand, Australia, Canada
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis BKorea, Republic of, Canada, Taiwan